Yahoo Buys Tumblr f...
Health Care: Drugs
Medivation Inc. (MDVN: NASDAQ)
$47.48 -0.05 | -0.11%
05/20/13 - 02:16 PM ET
Company Balance Sheet
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Assets | ||||
|---|---|---|---|---|
| Cash and Equivalents | 71.30M | 70.14M | 107.72M | 57.46M |
| Receivables | 35.46M | 12.54M | 21.19M | 6.49M |
| Inventories | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 344.22M | 168.19M | 237.01M | 294.08M |
| Property, Plant & Equipment, Gross | 15.40M | 2.14M | 1.85M | 1.66M |
| Accumulated Depreciation & Depletion | 2.13M | 1.42M | 992.00K | 565.00K |
| Property, Plant & Equipment, Net | 13.26M | 720.00K | 862.00K | 1.09M |
| Intangibles | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Non-Current Assets | 14.39M | 6.21M | 1.73M | 1.52M |
| Total Non-Current Assets | 27.65M | 6.93M | 2.59M | 2.61M |
| Liabilities & Shareholder Equity | ||||
| Total Assets | 371.87M | 175.12M | 239.60M | 296.69M |
| Accounts Payable | 2.07M | 5.59M | 3.23M | 4.84M |
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Current Liabilities | 0.00 | 270.00K | 5.19M | 800.00K |
| Total Current Liabilities | 84.89M | 89.63M | 88.97M | 104.26M |
| Long Term Debt | 196.01M | 0.00 | 0.00 | 0.00 |
| Deferred Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Non-Current Liabilities | 17.33M | 84.16M | 142.94M | 167.15M |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Non-Current Liabilities | 213.34M | 84.16M | 142.94M | 167.15M |
| Total Liabilities | 298.22M | 173.80M | 231.92M | 271.42M |
| Preferred Stock Equity | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Stock Equity | 73.64M | 1.32M | 7.68M | 25.27M |
| Common Par | 748.00K | 357.00K | 346.00K | 338.00K |
| Additional Paid In Capital | 364.41M | 251.24M | 218.79M | 202.36M |
| Cumulative Translation Adjustment | 0.00 | 0.00 | 0.00 | 0.00 |
| Retained Earnings | -291.55M | -250.29M | -211.45M | -177.41M |
| Treasury Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Equity Adjustments | 33.00K | 13.00K | 2.00K | -12.00K |
| Total Capitalization | 269.65M | 1.32M | 7.68M | 25.27M |
| Total Equity | 73.64M | 1.32M | 7.68M | 25.27M |
| Total Liabilities & Stock Equity | 371.87M | 175.12M | 239.60M | 296.69M |
| Total Common Shares Outstanding | 74.77M | 71.46M | 69.15M | 67.65M |
| Preferred Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Treasury Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic Weighted Shares Outstanding | 73.48M | 69.92M | 68.58M | 64.19M |
| Diluted Weighted Shares Outstanding | 73.48M | 69.92M | 68.58M | 64.19M |
| Number of Employees | 257 | 121 | 92 | 98 |
| Number of Part-Time Employees | 0 | 0 | 0 | 0 |
Portfolios with MDVN
- Portfolio NameUser Type
- ContributorDrugs Facing FDA Approval i...
- ContributorStocks Rising On Unusual Vo...
- ContributorRelative Strength Trades fo...
- User2012 performers
- ContributorFive Drug Stock Winners of ...
- ContributorStocks At New 52-Week Highs...
- Contributor10 Biotech Stocks Loved and...
- Contributor10 Biotech Trades for Secon...
- ContributorCancer Drug Stocks to Trade...
- UserASCO 2010 Part 2
Latest MDVN Headlines from TheStreet
- Medivation Inc. (MDVN): Today's Featured Health Care Mover 04.17.13 | 06:04 pm
- Top Insider Trades: JAKK SPB YELP MDVN 04.10.13 | 09:04 am
- Medivation Inc. (MDVN): Drugs' Featured Underachiever Of The Day 04.08.13 | 05:04 pm
- Medivation Inc. (MDVN): Today's Featured Health Care Laggard 03.11.13 | 05:03 pm
- Shocker! Sell-Sider Admits Dendreon Buy Rating Was Mistake 03.06.13 | 10:03 am
- Medivation Stock Falls On Unusually High Volume (MDVN) 03.01.13 | 12:03 pm
- Medivation Rises On Unusually High Volume (MDVN) 02.01.13 | 11:02 am
- Medivation Inc. (MDVN): Today's Featured Health Care Laggard 01.30.13 | 05:01 pm
- Medivation Stock Hits New 52-Week High (MDVN) 01.22.13 | 11:01 am
- J.P. Morgan Healthcare Confab Live Blog: Day One 01.07.13 | 07:01 am
Press Releases for MDVN
- Medivation And Pfizer Announce Results From Phase 3 Concert Trial Of Dimebon In Alzheimer’s Disease - Business Wire 01.17.12 | 07:01 am
- Medivation Announces Participation In 13th Annual BIO CEO & Investor Conference - PR Newswire 02.07.11 | 08:02 am
- Medivation Announces Participation In 29th Annual J.P. Morgan Healthcare Conference - PR Newswire 01.03.11 | 08:01 am
- Medivation Completes Enrollment In Phase 3 'CONCERT' Trial Of Dimebon Added To Donepezil In Patients With Alzheimer's Disease - PR Newswire 12.07.10 | 08:12 am
- Medivation And Astellas Complete Enrollment In Phase 3 Affirm Trial Of MDV3100 In Advanced Prostate Cancer - PR Newswire 11.29.10 | 04:11 pm
- Medivation Announces Third Quarter 2010 Financial Results Teleconference And Webcast On November 5, 2010 - PR Newswire 10.29.10 | 08:10 am
- Medivation Announces Participation In The NewsMakers In The Biotech Industry Conference - PR Newswire 10.19.10 | 08:10 am
- Medivation And Astellas Announce Initiation Of A Second Phase 3 Clinical Trial Of MDV3100 In Advanced Prostate Cancer - PR Newswire 09.29.10 | 08:09 am
- Medivation Announces Participation In The UBS Global Life Sciences Conference - PR Newswire 09.14.10 | 08:09 am
- Medivation Announces Second Quarter 2010 Financial Results Teleconference And Webcast On August 9, 2010 - PR Newswire 08.02.10 | 08:08 am
Partner Headlines for MDVN
- Neutral on Medivation - Analyst Blog - Zacks 12.31.12 | 05:12 pm
- Medivation Loses A Major Patent Dispute; A Blow To The Stock - Seeking Alpha 12.24.12 | 09:12 am
- Celgene, Regeneron Pharmaceutical Lead Biomed Group - Investor's Business Daily 11.30.12 | 05:11 pm
- Therapeutic Proteins Offer New Investment Opportunities - Seeking Alpha 11.24.12 | 05:11 am
- MDVN's Xtandi Off to a Strong Start - Analyst Blog - Zacks 11.13.12 | 09:11 am
- UPDATE: Jefferies & Company Reiterates Buy Rating, Raises PT on Medivation - Benzinga 11.12.12 | 09:11 am
- After-Hours Earnings Report for November 9, 2012 : MDVN, CRDN, LVB, SYUT, CWCO, WAVX - NASDAQ 11.09.12 | 07:11 pm
- 5 Big Buys By Columbus Circle Investors - Seeking Alpha 11.04.12 | 07:11 am
- Medivation-Astellas Launch Xtandi - Analyst Blog - NASDAQ 09.17.12 | 08:09 pm
- Medivation's Xtandi Approved - Analyst Blog - NASDAQ 09.04.12 | 07:09 pm
